CLEVELAND, OH – Before he played “God” actor Morgan Freeman played a street pimp nicknamed “Fast Black” in the film “Street Smart.” When Freeman added his voice to those promoting untested CoVid vaccines he opened up a public service announcement with the thought that he was “trusted.” Those of us who saw beyond his characterization of God saw an actor who once played a vicious pimp.
Over 167 million Americans and people living in the nation allowed themselves to become guinea pigs for a CoVid vaccine the Food & Drug Administration (FDA) approved for emergency used based only on the claims offered by the pharmaceutical companies. 2794 people have died as of April 6, 2021, according to the Centers for Disease Control’s (CDC) Vaccine Adverse Events Reporting System (VAERS) website. As of April 6, 2021 the CDC was advising Americans not to worry about the 2794 deaths.
Today, a week later, both the CDC and FDA are calling for a halt on Johnson & Johnson’s one-shot CoVid vaccine based on only six reported incidents of blood clotting among women 18 to 48. Johnson & Johnson’s one shot vaccine has been administered to over 7 million people; so the idea its use is being halted after six blood clotting incidents should be viewed as disproportionately alarming.
The aborted fetal tissue, pus from an African Green Monkey’s infected kidney, Hepatitis A, Hepatitis B, HPV and formaldehyde contained in the vaccines is creating exactly the problems Americans who refused to sacrifice themselves as guinea pigs expected.
The vaccine created by the manufacturer of fentanyl and the company led by a Russian named Alex Gorsky is not safe. Neither is the vaccine offered by AstraZeneca. Below is the full joint statement issued by the CDC and FDA.
As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.
CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.
Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.htmlexternal icon.
CDC and FDA will provide additional information and answer questions later today at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.
